Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
The Director, Regulatory CMC is responsible for defining and executing global CMC regulatory strategies for Dyne programs across all stages of development. This role plays a critical leadership role in enabling clinical registration, commercial readiness, and manufacturing lifecycle management.
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
Neurocrine Biosciences